Haematopoietic malignancies in rheumatoid arthritis: lymphoma risk and characteristics after exposure to tumour necrosis factor antagonists.
Askling J, Fored CM, Baecklund E, Brandt L, Backlin C, Ekbom A, Sundström C, Bertilsson L, Cöster L, Geborek P, Jacobsson LT, Lindblad S, Lysholm J, Rantapää-Dahlqvist S, Saxne T, Klareskog L, Feltelius N.
Askling J, et al.
Ann Rheum Dis. 2005 Oct;64(10):1414-20. doi: 10.1136/ard.2004.033241. Epub 2005 Apr 20.
Ann Rheum Dis. 2005.
PMID: 15843454
Free PMC article.